A New ERA in Scleroderma Interstitial Lung Disease and Renal Crisis: Rationale for Early Use of Endothelin Receptor Antagonists

被引：0
|
作者：
Sunseri, M. [1 ]
Gershner, K. [1 ]
Gunther, I. [1 ]
Brosnahan, S. [1 ]
机构：
[1] NYU, Langone Med Ctr, New York, NY USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1523
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Renal interstitial infusion of endothelin receptor antagonists improves renal function in Dahl salt-sensitive rats.
    Kassab, S
    Miller, T
    Novak, J
    Granger, J
    FASEB JOURNAL, 1997, 11 (03): : 150 - 150
  • [22] Peroxisome proliferator-activated receptor gamma activity in scleroderma interstitial lung disease
    Highland, K. B.
    Silver, R. M.
    Bogatkevich, G.
    Gilkeson, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 393 - 393
  • [23] Treating Scleroderma-Related Interstitial Lung Disease with a New Antifibrotic Agent
    Chen, M.
    Tseng, C.
    Tao, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [24] Endothelin Receptor Antagonists in Proteinuric Renal Disease: Every Rose Has Its Thorn
    Ritz, Eberhard
    Wenzel, Rene
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 21 (03): : 392 - 394
  • [25] Endothelin receptor antagonists in sickle cell disease: A promising new therapeutic approach
    Fox, Brandon M.
    Kasztan, Malgorzata
    LIFE SCIENCES, 2016, 159 : 15 - 19
  • [26] Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era
    Catena, Cristiana
    Colussi, GianLuca
    Sechi, Leonardo A.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2013, 168 (01) : C1 - C5
  • [27] THE ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (ENDOMT) IN SCLERODERMA CAN BE PREVENTED BY THE USE OF DUAL ENDOTHELIN RECEPTOR ANTAGONISTS BOSENTAN AND MACITENTAN
    Corallo, C.
    Cutolo, M.
    Soldano, S.
    Montella, A.
    Chirico, C.
    Nuti, R.
    Giordano, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 894 - 894
  • [28] NEW VIEWS OF DIAGNOSTIC AND PROGNOSTIC PARAMETERS IN SCLERODERMA ASSOCIATED INTERSTITIAL LUNG-DISEASE
    KONIG, G
    BEHR, J
    LUDERSCHMIDT, C
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1990, 49 (05): : 279 - 283
  • [29] Rationale and design of the Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease Study (MiREnDa)
    Hammer, Fabian
    Krane, Vera
    Stoerk, Stefan
    Roeser, Christoph
    Hofmann, Kirsten
    Pollak, Nils
    Allolio, Bruno
    Wanner, Christoph
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (02) : 400 - 405
  • [30] ULTRASOUND ASSESSED NAIL BED THICKNESS AS AN EARLY SCREENING MARKER FOR INTERSTITIAL LUNG DISEASE IN SCLERODERMA
    Dekate, P.
    Vodnala, S.
    Dudam, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1242 - 1243
12345